Funding for this research was provided by:
National Health and Medical Research Council (1092789)
National Institutes of Health (AI095192)
PATH's Malaria Vaccine Initiative (Burnet-03.07.14)
Australian Government Research Training Program Scholarship
Nijmegen Institute for Infection, Inflammation and Immunity (N4i) PhD scholarship
Received: 26 October 2017
Accepted: 10 April 2018
First Online: 30 April 2018
Ethics approval and consent to participate
: In all studies, adult participants and the parent or guardian of child participants provided written informed consent. Ethics approval was provided by the Medical Research Advisory Committee, Department of Health, Port Moresby, PNG (protocols 98.03, 01.13, 05.05); the Human Research and Ethics Committee of the Walter and Eliza Hall Institute of Medical Research, Australia (protocols 04.04, 06.06, 04.01); the Institutional Review Board for Human Investigation at University Hospitals of Cleveland for Case Western Reserve University, USA (protocol 02-04-04); the Ethical Review Committee at the Kenya Medical Research Institute, Kenya (protocol SSC867); and the Alfred Human Research and Ethics Committee, Melbourne, Australia (protocols 435-10, 224-17; 327-12).
: The authors declare they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.